| Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development JL Green, WF Dos Santos, ACK Fontana Biochemical pharmacology 193, 114786, 2021 | 98 | 2021 |
| Novel positive allosteric modulators of glutamate transport have neuroprotective properties in an in vitro excitotoxic model RM Falcucci, R Wertz, JL Green, O Meucci, J Salvino, ACK Fontana ACS chemical neuroscience 10 (8), 3437-3453, 2019 | 47 | 2019 |
| Elucidation of the Structure and Synthesis of Neuroprotective Low Molecular Mass Components of the Parawixia bistriata Spider Venom YM Forster, JL Green, A Khatiwada, JL Liberato, PA Narayana Reddy, ... ACS chemical neuroscience 11 (11), 1573-1596, 2020 | 13 | 2020 |
| CD33 and SHP-1/PTPN6 Interaction in Alzheimer’s Disease L Beckers, M Rashid, AJ Lee, ZK Chatila, KA Tamucci, RC Talcoff, JL Hall, ... Genes 15 (9), 1204, 2024 | 2 | 2024 |
| In vitro neuroprotective properties of positive allosteric modulators and expression enhancers of EAAT2 J Green Drexel University, 2019 | 1 | 2019 |
| CD33 competitive inhibitor peptide IMAD‐001 modulates innate immunity in Alzheimer’s disease JL Green, D Dressman, M Rashid, R Hobson, W Elyaman, EM Bradshaw Alzheimer's & Dementia 20, e089331, 2024 | | 2024 |
